• Mankind Cefastar Cv Dry Syrup Cefpodoxime Proxetil Oral Suspension For Dogs And Cats

Mankind Cefastar CV Dry Syrup (Cefpodoxime Proxetil) Oral Suspension for Dogs and Cats

Low stock! Only 10 left
Volume
Rs. 197.00 INR
Rs. 197.00 INR Rs. 197.00 INR
Tax included. Shipping calculated at checkout.
  • Fully secure checkout
  • Trusted by thousands
  • Rated and reviewed

Want next day delivery? Be quick!

Mankind Cefastar CV Dry Syrup (Cefpodoxime Proxetil) Oral Suspension for Dogs and Cats – Premium Daily Nutrition for Dogs

A pediatric formulation of the antibiotic combination used to treat bacterial infections by inhibiting bacterial cell wall synthesis and overcoming resistance mechanisms. Composition: Cefpodoxime Proxetil: Specific dosage per 5 ml not specified in the provided sources.

How to Use

Follow the feeding guide on the packaging based on your dog's weight and age. Always keep fresh water available.

Safety Information

  • Consult your veterinarian before significantly changing your dog's diet, especially if they have a known health condition.
  • Store in a cool, dry place and keep the pack sealed after opening.
Mankind Cefastar CV Dry Syrup (Cefpodoxime Proxetil) Oral Suspension for Dogs and Cats

Rs. 197.00 INR

Does it come with a warranty?

Add your collapsible row content here. If it's set to open one row at a time, consider keeping the content in each row about the same length.

What happens if I don't like it?

Add your collapsible row content here. If it's set to open one row at a time, consider keeping the content in each row about the same length.

How fast is shipping?

Add your collapsible row content here. If it's set to open one row at a time, consider keeping the content in each row about the same length.

What's the returns policy?

Add your collapsible row content here. If it's set to open one row at a time, consider keeping the content in each row about the same length.

Questions about this product?
Don't be a stranger.

Get in touch

Exclusive discounts, just for you. Sign up now.